CBD Life Sciences (CBD Life Sciences) Total Stockholders Equity : $0.21 Mil (As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Total Stockholders Equity?

CBD Life Sciences's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $0.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CBD Life Sciences's Book Value per Share for the quarter that ended in Sep. 2015 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CBD Life Sciences's Debt-to-Equity for the quarter that ended in Sep. 2015 was 0.00.

CBD Life Sciences Total Stockholders Equity Historical Data

The historical data trend for CBD Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Total Stockholders Equity Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Total Stockholders Equity

0.48

0.40

0.08

-0.01

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Stockholders Equity	Get a 7-Day Free Trial											-0.17	-0.01	0.26	0.23	0.21

CBD Life Sciences (OTCPK:CBDL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CBD Life Sciences's Book Value per Share for the quarter that ended in Sep. 2015 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(0.209	-	0.016)	/	0
	=	N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CBD Life Sciences's Debt-to-Equity for the quarter that ended in Sep. 2015 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.209
	=	0.00

CBD Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.